Influence of novel oral anticoagulants on anticoagulation care management

被引:2
|
作者
Janzic, Andrej [1 ]
Kos, Mitja [1 ]
机构
[1] Univ Ljubljana, Fac Pharm, Ljubljana 1000, Slovenia
关键词
novel oral anticoagulants; health care management; anticoagulation care; NONVALVULAR ATRIAL-FIBRILLATION; ANTITHROMBOTIC THERAPY; COST-EFFECTIVENESS; STROKE PREVENTION; GUIDELINES; PHYSICIANS; OPTIMIZE; QUALITY; CLINICS; MODELS;
D O I
10.1515/acph-2017-0030
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Anticoagulation treatment was recently improved by the introduction of novel oral anticoagulants (NOACs). Using a combination of qualitative and quantitative methods, this study explores the effects of the introduction of NOACs on anticoagulation care in Slovenia. Face-to-face interviews with key stakeholders revealed evolvement and challenges of anticoagulation care from different perspectives. Obtained information was further explored through the analysis of nationwide data of drug prescriptions and realization of health care services. Simplified management of anticoagulation treatment with NOACs and their high penetration expanded the capacity of anticoagulation clinics, and consequentially the treated population increased by more than 50 % in the last 5 years. The main challenge concerned the expenditures for medicines, which increased approximately 10 times in just a few years. At the same time, the anticoagulation clinics and their core organisation were not affected, which is not expected to change, since they are vital in delivering high-quality care.
引用
收藏
页码:397 / 406
页数:10
相关论文
共 50 条
  • [31] Management of novel oral anticoagulants for GI endoscopy procedures
    Paggi, Silvia
    Rondonotti, Emanuele
    Amato, Arnaldo
    Radaelli, Franco
    GASTROINTESTINAL ENDOSCOPY, 2016, 83 (06) : 1304 - 1305
  • [32] Management of epistaxis in patients on novel oral anticoagulation therapy
    Ho, J. P. K.
    Bari, N.
    Riffat, F.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2020, 134 (04): : 316 - 322
  • [33] Practical introduction of novel oral anticoagulants through an anticoagulation nurse. The Leeuwarden model
    Folkeringa, R. J.
    Geven, L. M.
    Veldhuis, T.
    Hoogendoorn, M.
    Hofma, S. H.
    Van Roon, E.
    NETHERLANDS HEART JOURNAL, 2014, 22 (06) : 297 - 300
  • [34] Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants
    Ng K.H.
    Hart R.G.
    Eikelboom J.W.
    Cardiology and Therapy, 2013, 2 (2) : 135 - 149
  • [35] Practical introduction of novel oral anticoagulants through an anticoagulation nurse. The Leeuwarden model
    R. J. Folkeringa
    L. M. Geven
    T. Veldhuis
    M. Hoogendoorn
    S. H. Hofma
    E. Van Roon
    Netherlands Heart Journal, 2014, 22 : 297 - 300
  • [36] The Novel Oral Anticoagulants
    Rojas-Hernandez, Cristhiam M.
    Garcia, David A.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2013, 39 (02): : 117 - 126
  • [37] Novel oral anticoagulants
    Khoo, C. W.
    Tay, K. -H.
    Shantsila, E.
    Lip, G. Y. H.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (04) : 630 - 641
  • [38] Trends in the prescription of novel oral anticoagulants in UK primary care
    Loo, Simone Y.
    Dell'Aniello, Sophie
    Huiart, Laetitia
    Renoux, Christel
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (09) : 2096 - 2106
  • [39] Non-vitamin K‑dependent oral anticoagulants: Emergency management in patients with bleeding under oral anticoagulation
    Koscielny J.
    Rosenthal C.
    von Heymann C.
    Gefässchirurgie, 2017, 22 (8) : 585 - 599
  • [40] Changes in the landscape of anticoagulation: a focus on direct oral anticoagulants
    Haematol, Lancet
    Ageno, Walter
    Caramelli, Bruno
    Donadini, Marco Paolo
    Girardi, Laura
    Riva, Nicoletta
    LANCET HAEMATOLOGY, 2024, 11 (12): : e938 - e950